Ohr Pharmaceutical to Announce Fiscal Second Quarter 2017 Results on May 11

NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) — Ohr Pharmaceutical, Inc. (OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that it will report financial results for its second fiscal quarter ended March 31, 2017 after the market close on Thursday, May 11, 2017.  The Company will also hold a live investor conference call and webcast at 5:00pm Eastern Time.